1. Home
  2. LOOP vs ONCY Comparison

LOOP vs ONCY Comparison

Compare LOOP & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

N/A

Current Price

$0.95

Market Cap

66.2M

Sector

Industrials

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

N/A

Current Price

$0.85

Market Cap

98.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOOP
ONCY
Founded
2010
1998
Country
Canada
Canada
Employees
N/A
N/A
Industry
Major Chemicals
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.2M
98.7M
IPO Year
2010
2002

Fundamental Metrics

Financial Performance
Metric
LOOP
ONCY
Price
$0.95
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
65.9K
1.6M
Earning Date
05-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
N/A
EPS
N/A
N/A
Revenue
$10,889,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.73
$0.56
52 Week High
$1.99
$1.51

Technical Indicators

Market Signals
Indicator
LOOP
ONCY
Relative Strength Index (RSI) 28.59 46.81
Support Level N/A $0.82
Resistance Level $1.44 $1.14
Average True Range (ATR) 0.12 0.09
MACD -0.05 -0.00
Stochastic Oscillator 21.77 16.74

Price Performance

Historical Comparison
LOOP
ONCY

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: